Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
doxylamine succinate + pyridoxine hydrochloride + folic acid
- Development stage
- Unknown
- Lead developer
- Ind Blues Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
DopFol-OD is a fixed-dose combination pharmaceutical product marketed by Ind Blues Pharma, primarily indicated for the management of nausea and vomiting of pregnancy (NVP), commonly known as morning sickness. The formulation consists of doxylamine succinate, a first-generation antihistamine that acts as a competitive antagonist at histamine H1 receptors to provide antiemetic effects; pyridoxine hydrochloride (Vitamin B6), which is involved in amino acid metabolism and has been shown to reduce nausea; and folic acid (Vitamin B9), which is essential for preventing neural tube defects in the developing fetus. The "OD" designation indicates a once-daily, sustained-release formulation designed to provide consistent symptom relief throughout the day and improve patient compliance.
- Brand names
- DopFol-OD
- Other names
- doxylamine + pyridoxine + folic aciddoxylamine succinate + pyridoxine hydrochloride + folic acid
02
Targets
mAChR (Muscarinic acetylcholine receptors)FOLR1 (FRα)HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on doxylamine succinate + pyridoxine hydrochloride + folic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on doxylamine succinate + pyridoxine hydrochloride + folic acid.